Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

Clinical trial NCT04339101 · COMPLETED

Trial details

NCT number: NCT04339101
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Hematologic and Lymphocytic Disorder Myelodysplastic Syndrome Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2020-11-11
Primary completion: 2023-05-22
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.